US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Immuneering Corp

3.86

+0.03000.78%

Volume:747.68K

Turnover:2.87M

Market Cap:249.24M

PE:-3.94

High:3.92

Open:3.78

Low:3.74

Close:3.83

52wk High:8.48

52wk Low:3.74

Shares:64.57M

Float Shares:49.21M

Volume Ratio:1.20

T/O Rate:1.52%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.9796

EPS(LYR):-1.2729

ROE:-52.15%

ROA:-32.77%

PB:1.31

PE(LYR):-3.03

Loading ...

Overview Company News Filings

Immuneering doses first patient in Phase 3 MAPKeeper 301 trial for first-line metastatic pancreatic cancer

Immuneering - Topline Data From Phase 3 Trial Expected in Mid-2028

THOMSON REUTERS

Immuneering Buy Rating Reaffirmed as Analyst Sees ASCO Sell-Off as Overdone; $11 Price Target Maintained

Immuneering Advances Atebimetinib With Positive Phase 2a Results

Immuneering - 17.3 Month Median Overall Survival Observed in 320 Mg ITT Population as of April 24, 2026 - SEC Filing

THOMSON REUTERS

Immuneering - Announces Updated Phase 2a Data for Atebimetinib in Pancreatic Cancer - SEC Filing

THOMSON REUTERS

Immuneering says atebimetinib plus chemo posts 17.3-month median survival in Phase 2a first-line pancreatic cancer study

Immuneering Presents Compelling 17.3-Month Median Overall Survival and Favorable Tolerability with Atebimetinib + Chemotherapy in First-Line Pancreatic Cancer Patients at ASCO

Analysts Offer Insights on Healthcare Companies: Immuneering (IMRX) and Cencora (COR)

Immuneering says atebimetinib-chemo trial shows 17.3-month median survival in pancreatic cancer

Immuneering Reports 17.3 Months Median Overall Survival in First-Line Metastatic Pancreatic Cancer Patients Treated With Atebimetinib Plus Chemotherapy

THOMSON REUTERS

Immuneering Corp - Only Anemia (16%) and Neutropenia (18%) Grade 3+ Adverse Events in ≥10% of Patients

THOMSON REUTERS

Immuneering Corp - Full Data From 55 Patients to Be Presented at Asco on June 1, 2026

THOMSON REUTERS

Immuneering Corp - Reports 17.3-Month Median Overall Survival as of April 24, 2026 Data Cutoff

THOMSON REUTERS

Immuneering Corp - Phase 3 Mapkeeper 301 Trial Recruiting; First Patient Dosing Expected Mid-2026

THOMSON REUTERS

Immuneering Reports 17.3 Months Median Overall Survival in First-Line Metastatic Pancreatic Cancer Patients Treated with Atebimetinib Plus Chemotherapy

Immuneering Is Maintained at Buy by Chardan Capital

Immuneering (IMRX) Gets a Buy from Chardan Capital

Mizuho Securities Sticks to Their Buy Rating for Immuneering (IMRX)

Analysts Are Bullish on Top Healthcare Stocks: Immuneering (IMRX), Galectin Therapeutics (GALT)

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/stock/IMRX/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"IMRX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IMRX\",,,,,undefined,":{"symbol":"IMRX","market":"US","secType":"STK","nameCN":"Immuneering Corp","latestPrice":3.86,"timestamp":1791403200000,"preClose":3.83,"halted":0,"volume":747682,"delay":0,"changeRate":0.007832898172323709,"floatShares":49210000,"shares":64569967,"eps":-0.979559,"marketStatus":"Pre-Mkt","change":0.03,"latestTime":"10-08 04:52:24 EDT","open":3.78,"high":3.915,"low":3.74,"amount":2873230.2970774,"amplitude":0.045692,"askPrice":5.31,"askSize":100,"bidPrice":3.44,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-0.979559,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1791466200000},"marketStatusCode":1,"adr":0,"listingDate":1627617600000,"exchange":"NASDAQ","adjPreClose":3.86,"postHourTrading":{"tag":"盘后","latestPrice":3.89,"preClose":3.86,"latestTime":"19:30 EDT","volume":4711,"amount":18196.1723,"timestamp":1791415802125,"change":0.03,"changeRate":0.007772,"amplitude":0.007772},"volumeRatio":1.2039587798316906,"impliedVol":1.7657,"impliedVolPercentile":0.76},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IMRX\",,,,,undefined,":{"symbol":"IMRX","floatShares":49210000,"roa":"-32.77%","roe":"-52.15%","lyrEps":-1.27295,"volumeRatio":1.2039587798316906,"shares":64569967,"dividePrice":0,"high":3.915,"amplitude":0.045692,"preClose":3.83,"low":3.74,"week52Low":3.74,"pbRate":"1.31","psRate":"547780.38","week52High":8.48,"institutionHeld":0,"latestPrice":3.86,"eps":-0.979559,"divideRate":0,"volume":747682,"delay":0,"ttmEps":-0.979559,"open":3.78,"prevYearClose":6.58,"prevWeekClose":4.07,"prevMonthClose":4.095,"prevQuarterClose":4.095,"fiveDayClose":4.095,"twentyDayClose":4.61,"sixtyDayClose":5.21},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IMRX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2022-02-08","symbol":"IMRX","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1644296400000,"reportTimeType":"","actualEps":null},{"market":"US","date":"2021-09-09","symbol":"IMRX","fiscalQuarterEnding":"2021/06","expectedEps":-1.78,"name":null,"time":"","type":"earning","dateTimestamp":1631160000000,"reportTimeType":"","actualEps":-1.61}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IMRX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"IMRX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.2857,"buy":0.7143,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.7143,"analysts":7,"updateTime":1786075200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/IMRX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"IMRX","date":"2026-10-07","current":-3.940549,"percent":0.49341,"low":-32.904786,"twenty":-6.207216,"median":-4.246328,"eighty":-1.165266,"high":-0.544763,"avg":-4.931035,"sd":4.953816,"marketCap":247791049},"quantilePoints":[{"date":"2021-10-08","current":-29.393669,"twenty":-34.79613,"median":-30.963594,"eighty":-27.123376,"marketCap":718743753},{"date":"2021-10-15","current":-26.370502,"twenty":-34.757241,"median":-30.737841,"eighty":-25.579175,"marketCap":644820271},{"date":"2021-10-22","current":-27.420655,"twenty":-34.594392,"median":-30.019518,"eighty":-25.579175,"marketCap":670498954},{"date":"2021-10-29","current":-28.746605,"twenty":-34.370779,"median":-29.565885,"eighty":-25.859215,"marketCap":702921534},{"date":"2021-11-05","current":-31.674304,"twenty":-34.314876,"median":-29.74372,"eighty":-26.166836,"marketCap":774510591},{"date":"2021-11-12","current":-25.289652,"twenty":-34.283278,"median":-29.565885,"eighty":-26.166836,"marketCap":722963518},{"date":"2021-11-19","current":-22.558333,"twenty":-33.710006,"median":-28.972469,"eighty":-25.187144,"marketCap":644882421},{"date":"2021-11-26","current":-20.453131,"twenty":-32.879093,"median":-28.778428,"eighty":-24.841544,"marketCap":584700312},{"date":"2021-12-03","current":-17.576626,"twenty":-32.696112,"median":-28.497326,"eighty":-23.741458,"marketCap":502468724},{"date":"2021-12-10","current":-19.636457,"twenty":-32.324185,"median":-28.163187,"eighty":-22.296998,"marketCap":561353804},{"date":"2021-12-17","current":-19.309788,"twenty":-32.100427,"median":-27.505516,"eighty":-21.262189,"marketCap":552015201},{"date":"2021-12-23","current":-18.874241,"twenty":-32.022843,"median":-27.430931,"eighty":-20.552946,"marketCap":539564079},{"date":"2021-12-31","current":-14.887633,"twenty":-31.674304,"median":-27.177075,"eighty":-20.40776,"marketCap":425597617},{"date":"2022-01-07","current":-14.243147,"twenty":-31.658256,"median":-26.71902,"eighty":-19.482197,"marketCap":407173478},{"date":"2022-01-14","current":-11.969031,"twenty":-31.51519,"median":-26.42354,"eighty":-19.028489,"marketCap":342162587},{"date":"2022-01-21","current":-11.103578,"twenty":-31.481245,"median":-26.031059,"eighty":-18.640116,"marketCap":317421599},{"date":"2022-01-28","current":-9.206947,"twenty":-31.447301,"median":-25.379254,"eighty":-18.098783,"marketCap":263201990},{"date":"2022-02-04","current":-9.022808,"twenty":-31.303678,"median":-25.09002,"eighty":-15.312994,"marketCap":257937950},{"date":"2022-02-11","current":-8.746599,"twenty":-31.202956,"median":-24.614944,"eighty":-14.27445,"marketCap":250041890},{"date":"2022-02-18","current":-7.669387,"twenty":-31.093007,"median":-23.973184,"eighty":-13.003892,"marketCap":219247257},{"date":"2022-02-25","current":-7.227453,"twenty":-31.006024,"median":-23.297074,"eighty":-12.195522,"marketCap":206613562},{"date":"2022-03-04","current":-6.104206,"twenty":-30.912677,"median":-22.394998,"eighty":-11.324544,"marketCap":174502919},{"date":"2022-03-11","current":-5.104662,"twenty":-30.843317,"median":-21.805179,"eighty":-10.260222,"marketCap":171188670},{"date":"2022-03-18","current":-5.505799,"twenty":-30.766019,"median":-21.218553,"eighty":-9.206947,"marketCap":184641093},{"date":"2022-03-25","current":-5.702435,"twenty":-30.685675,"median":-20.552946,"eighty":-9.004394,"marketCap":191235417},{"date":"2022-04-01","current":-5.851878,"twenty":-30.388662,"median":-20.434983,"eighty":-8.728185,"marketCap":196247104},{"date":"2022-04-08","current":-5.560857,"twenty":-30.095892,"median":-19.881459,"eighty":-7.906926,"marketCap":186487503},{"date":"2022-04-14","current":-5.026008,"twenty":-29.909199,"median":-19.636457,"eighty":-7.155639,"marketCap":168550940},{"date":"2022-04-22","current":-4.632737,"twenty":-29.741472,"median":-19.332473,"eighty":-6.57376,"marketCap":155362291},{"date":"2022-04-29","current":-3.909117,"twenty":-29.600328,"median":-19.028489,"eighty":-6.236786,"marketCap":131095176},{"date":"2022-05-06","current":-3.863096,"twenty":-29.300322,"median":-18.77442,"eighty":-6.076585,"marketCap":129551818},{"date":"2022-05-13","current":-3.301241,"twenty":-29.085169,"median":-18.248113,"eighty":-5.773224,"marketCap":132718053},{"date":"2022-05-20","current":-2.868076,"twenty":-28.958498,"median":-17.902974,"eighty":-5.560857,"marketCap":115303756},{"date":"2022-05-27","current":-3.032154,"twenty":-28.873896,"median":-15.642603,"eighty":-5.43973,"marketCap":121900081},{"date":"2022-06-03","current":-3.117474,"twenty":-28.772063,"median":-15.136221,"eighty":-5.357929,"marketCap":125330170},{"date":"2022-06-10","current":-3.248736,"twenty":-28.702053,"median":-14.560786,"eighty":-5.169159,"marketCap":130607230},{"date":"2022-06-17","current":-3.019028,"twenty":-28.513237,"median":-14.243147,"eighty":-5.057469,"marketCap":121372375},{"date":"2022-06-24","current":-2.966523,"twenty":-28.470807,"median":-13.018623,"eighty":-4.797911,"marketCap":119261551},{"date":"2022-07-01","current":-3.281552,"twenty":-28.322301,"median":-12.535258,"eighty":-4.516125,"marketCap":131926495},{"date":"2022-07-08","current":-4.77794,"twenty":-28.19501,"median":-11.72965,"eighty":-4.342773,"marketCap":192084976},{"date":"2022-07-15","current":-4.764813,"twenty":-27.798285,"median":-11.342958,"eighty":-4.376588,"marketCap":191557270},{"date":"2022-07-22","current":-4.679493,"twenty":-27.596741,"median":-11.177233,"eighty":-4.47804,"marketCap":188127181},{"date":"2022-07-29","current":-4.279144,"twenty":-27.467328,"median":-9.768571,"eighty":-4.342843,"marketCap":172032149},{"date":"2022-08-05","current":-4.200386,"twenty":-27.441339,"median":-9.354258,"eighty":-4.248161,"marketCap":168865913},{"date":"2022-08-12","current":-3.583967,"twenty":-27.424765,"median":-9.206947,"eighty":-4.220076,"marketCap":156770256},{"date":"2022-08-19","current":-4.036488,"twenty":-27.284877,"median":-8.99979,"eighty":-4.217662,"marketCap":176564480},{"date":"2022-08-26","current":-3.638269,"twenty":-27.191847,"median":-8.820255,"eighty":-4.112624,"marketCap":159145562},{"date":"2022-09-02","current":-4.489009,"twenty":-26.964607,"median":-8.663737,"eighty":-4.062597,"marketCap":196358704},{"date":"2022-09-09","current":-5.351815,"twenty":-26.847844,"median":-8.102113,"eighty":-4.089364,"marketCap":234099692},{"date":"2022-09-16","current":-7.409278,"twenty":-26.701741,"median":-7.540489,"eighty":-4.110182,"marketCap":324097431},{"date":"2022-09-23","current":-6.184454,"twenty":-26.518292,"median":-7.478664,"eighty":-4.129108,"marketCap":270521064},{"date":"2022-09-30","current":-8.640135,"twenty":-26.430952,"median":-7.511849,"eighty":-4.171405,"marketCap":377937721},{"date":"2022-10-07","current":-7.753194,"twenty":-26.391717,"median":-7.604938,"eighty":-4.197576,"marketCap":339141042},{"date":"2022-10-14","current":-7.759227,"twenty":-26.166836,"median":-7.710958,"eighty":-4.204957,"marketCap":339404965},{"date":"2022-10-21","current":-7.825597,"twenty":-25.859215,"median":-7.75621,"eighty":-4.215247,"marketCap":342308118},{"date":"2022-10-28","current":-8.145379,"twenty":-25.579175,"median":-7.831631,"eighty":-4.220076,"marketCap":356296036},{"date":"2022-11-04","current":-6.226689,"twenty":-25.361334,"median":-7.837664,"eighty":-4.222148,"marketCap":272368525},{"date":"2022-11-11","current":-4.159708,"twenty":-25.187144,"median":-7.759227,"eighty":-4.222148,"marketCap":199883821},{"date":"2022-11-18","current":-3.846494,"twenty":-25.101534,"median":-7.732076,"eighty":-4.197576,"marketCap":184833124},{"date":"2022-11-25","current":-3.610209,"twenty":-25.039205,"median":-7.656988,"eighty":-4.124428,"marketCap":173479089},{"date":"2022-12-02","current":-3.25853,"twenty":-24.902263,"median":-7.535984,"eighty":-4.049542,"marketCap":156580060},{"date":"2022-12-09","current":-2.846405,"twenty":-24.654192,"median":-7.415311,"eighty":-3.946191,"marketCap":136776511},{"date":"2022-12-16","current":-2.302401,"twenty":-24.266189,"median":-7.240336,"eighty":-3.838309,"marketCap":110635827},{"date":"2022-12-23","current":-2.401311,"twenty":-24.011725,"median":-7.167608,"eighty":-3.788803,"marketCap":115388678},{"date":"2022-12-30","current":-2.665071,"twenty":-23.915253,"median":-6.893039,"eighty":-3.65307,"marketCap":128062950},{"date":"2023-01-06","current":-2.165026,"twenty":-23.683527,"median":-6.748692,"eighty":-3.620168,"marketCap":104034644},{"date":"2023-01-13","current":-2.434281,"twenty":-23.297074,"median":-6.444863,"eighty":-3.571744,"marketCap":116972962},{"date":"2023-01-20","current":-2.384826,"twenty":-23.091187,"median":-6.389597,"eighty":-3.539873,"marketCap":114596536},{"date":"2023-01-27","current":-2.445271,"twenty":-22.654609,"median":-6.277203,"eighty":-3.410189,"marketCap":117501057},{"date":"2023-02-03","current":-2.181511,"twenty":-22.296998,"median":-6.214689,"eighty":-3.365467,"marketCap":104826786},{"date":"2023-02-10","current":-2.077107,"twenty":-22.054954,"median":-6.163676,"eighty":-3.32093,"marketCap":99809886},{"date":"2023-02-17","current":-2.522201,"twenty":-21.846299,"median":-6.058171,"eighty":-3.281552,"marketCap":121197719},{"date":"2023-02-24","current":-2.577151,"twenty":-21.548222,"median":-5.985345,"eighty":-3.232985,"marketCap":123838193},{"date":"2023-03-03","current":-2.79695,"twenty":-21.290871,"median":-5.847945,"eighty":-3.116748,"marketCap":134400085},{"date":"2023-03-10","current":-3.940801,"twenty":-21.215562,"median":-5.7103,"eighty":-3.10326,"marketCap":199063900},{"date":"2023-03-17","current":-4.223408,"twenty":-20.877378,"median":-5.560857,"eighty":-3.116748,"marketCap":213339399},{"date":"2023-03-24","current":-5.427105,"twenty":-20.595727,"median":-5.505799,"eighty":-3.117474,"marketCap":274142450},{"date":"2023-03-31","current":-5.081696,"twenty":-20.542057,"median":-5.445473,"eighty":-3.164729,"marketCap":256694618},{"date":"2023-04-06","current":-4.375178,"twenty":-20.502131,"median":-5.427125,"eighty":-3.201482,"marketCap":221005871},{"date":"2023-04-14","current":-6.463332,"twenty":-20.438612,"median":-5.432339,"eighty":-3.225109,"marketCap":326485946},{"date":"2023-04-21","current":-6.832312,"twenty":-20.413204,"median":-5.498193,"eighty":-3.252654,"marketCap":345124456},{"date":"2023-04-28","current":-6.132304,"twenty":-20.19724,"median":-5.560857,"eighty":-3.267739,"marketCap":309764542},{"date":"2023-05-05","current":-4.649577,"twenty":-19.866941,"median":-5.533328,"eighty":-3.281552,"marketCap":234866707},{"date":"2023-05-11","current":-4.111377,"twenty":-19.803422,"median":-5.498193,"eighty":-3.28549,"marketCap":210590323},{"date":"2023-05-18","current":-4.945072,"twenty":-19.678198,"median":-5.458607,"eighty":-3.297303,"marketCap":253293360},{"date":"2023-05-26","current":-3.72879,"twenty":-19.513049,"median":-5.429742,"eighty":-3.311742,"marketCap":190993723},{"date":"2023-06-02","current":-5.379051,"twenty":-19.431382,"median":-5.427105,"eighty":-3.316992,"marketCap":275522339},{"date":"2023-06-07","current":-5.281977,"twenty":-19.380567,"median":-5.411414,"eighty":-3.319617,"marketCap":270550068},{"date":"2023-06-15","current":-5.321949,"twenty":-19.337011,"median":-5.419259,"eighty":-3.32093,"marketCap":272597473},{"date":"2023-06-23","current":-6.446867,"twenty":-19.309788,"median":-5.427145,"eighty":-3.32093,"marketCap":330217326},{"date":"2023-06-30","current":-5.470415,"twenty":-19.204528,"median":-5.432339,"eighty":-3.331431,"marketCap":280202124},{"date":"2023-07-07","current":-5.658853,"twenty":-19.043008,"median":-5.458607,"eighty":-3.349234,"marketCap":289854180},{"date":"2023-07-14","current":-5.413313,"twenty":-19.015785,"median":-5.464511,"eighty":-3.358014,"marketCap":277277258},{"date":"2023-07-21","current":-5.83016,"twenty":-18.946824,"median":-5.498966,"eighty":-3.361598,"marketCap":298628777},{"date":"2023-07-28","current":-5.35621,"twenty":-18.834312,"median":-5.502382,"eighty":-3.366756,"marketCap":274352393},{"date":"2023-08-04","current":-5.856075,"twenty":-18.640116,"median":-5.538938,"eighty":-3.368463,"marketCap":299956153},{"date":"2023-08-11","current":-5.640407,"twenty":-18.451374,"median":-5.556069,"eighty":-3.380171,"marketCap":292640150},{"date":"2023-08-18","current":-4.969198,"twenty":-18.244355,"median":-5.538938,"eighty":-3.402313,"marketCap":257815972},{"date":"2023-08-25","current":-5.454273,"twenty":-18.229322,"median":-5.536059,"eighty":-3.424628,"marketCap":282983025},{"date":"2023-09-01","current":-5.082007,"twenty":-18.098783,"median":-5.505799,"eighty":-3.473171,"marketCap":263668775},{"date":"2023-09-08","current":-4.732301,"twenty":-17.576626,"median":-5.490588,"eighty":-3.478329,"marketCap":245525085},{"date":"2023-09-15","current":-4.320552,"twenty":-16.848713,"median":-5.45644,"eighty":-3.500309,"marketCap":224162354},{"date":"2023-09-22","current":-4.360034,"twenty":-15.642603,"median":-5.442993,"eighty":-3.543057,"marketCap":226210835},{"date":"2023-09-29","current":-4.416439,"twenty":-15.41427,"median":-5.427145,"eighty":-3.548423,"marketCap":229137237},{"date":"2023-10-06","current":-4.207743,"twenty":-15.180414,"median":-5.412363,"eighty":-3.550464,"marketCap":218309551},{"date":"2023-10-13","current":-3.522434,"twenty":-14.937351,"median":-5.379051,"eighty":-3.550464,"marketCap":182753773},{"date":"2023-10-20","current":-3.384244,"twenty":-14.860012,"median":-5.35907,"eighty":-3.513584,"marketCap":175584090},{"date":"2023-10-27","current":-3.023258,"twenty":-14.841598,"median":-5.356356,"eighty":-3.478329,"marketCap":156855120},{"date":"2023-11-03","current":-3.384244,"twenty":-14.279974,"median":-5.34622,"eighty":-3.412814,"marketCap":175584090},{"date":"2023-11-10","current":-2.947163,"twenty":-14.252354,"median":-5.321949,"eighty":-3.384244,"marketCap":152172878},{"date":"2023-11-17","current":-2.913665,"twenty":-14.243147,"median":-5.300305,"eighty":-3.384244,"marketCap":150443281},{"date":"2023-11-24","current":-4.364829,"twenty":-13.705461,"median":-5.294869,"eighty":-3.382454,"marketCap":225372231},{"date":"2023-12-01","current":-3.718608,"twenty":-13.129106,"median":-5.237177,"eighty":-3.384244,"marketCap":192005433},{"date":"2023-12-08","current":-4.631254,"twenty":-12.974429,"median":-5.212533,"eighty":-3.384244,"marketCap":239128718},{"date":"2023-12-15","current":-4.381835,"twenty":-12.812387,"median":-5.168731,"eighty":-3.384244,"marketCap":226250305},{"date":"2023-12-22","current":-3.956689,"twenty":-12.49751,"median":-5.15972,"eighty":-3.384244,"marketCap":204298464},{"date":"2023-12-29","current":-4.421515,"twenty":-12.271019,"median":-5.151886,"eighty":-3.384244,"marketCap":228299143},{"date":"2024-01-05","current":-3.837648,"twenty":-12.044528,"median":-5.118331,"eighty":-3.384244,"marketCap":198151949},{"date":"2024-01-12","current":-3.531543,"twenty":-11.586022,"median":-5.092178,"eighty":-3.384244,"marketCap":182346623},{"date":"2024-01-19","current":-3.293462,"twenty":-11.446076,"median":-5.084468,"eighty":-3.384244,"marketCap":170053593},{"date":"2024-01-26","current":-3.514538,"twenty":-11.37242,"median":-5.081696,"eighty":-3.384244,"marketCap":181468550},{"date":"2024-02-02","current":-3.256616,"twenty":-11.315338,"median":-5.051704,"eighty":-3.384244,"marketCap":168151100},{"date":"2024-02-09","current":-3.452183,"twenty":-11.269303,"median":-5.026008,"eighty":-3.380663,"marketCap":178248946},{"date":"2024-02-16","current":-3.797968,"twenty":-11.162502,"median":-4.979499,"eighty":-3.384244,"marketCap":196103110},{"date":"2024-02-23","current":-3.639247,"twenty":-10.897342,"median":-4.964988,"eighty":-3.384244,"marketCap":187907756},{"date":"2024-03-01","current":-3.514538,"twenty":-10.260222,"median":-4.924075,"eighty":-3.384244,"marketCap":181468550},{"date":"2024-03-08","current":-3.658244,"twenty":-9.709646,"median":-4.89778,"eighty":-3.384244,"marketCap":195612256},{"date":"2024-03-15","current":-1.58816,"twenty":-9.573383,"median":-4.876386,"eighty":-3.370913,"marketCap":84921488},{"date":"2024-03-22","current":-1.495061,"twenty":-9.38372,"median":-4.839647,"eighty":-3.363712,"marketCap":79943332},{"date":"2024-03-28","current":-1.330768,"twenty":-9.206947,"median":-4.791108,"eighty":-3.351606,"marketCap":71158350},{"date":"2024-04-05","current":-1.286957,"twenty":-9.206947,"median":-4.774314,"eighty":-3.322939,"marketCap":68815689},{"date":"2024-04-12","current":-1.139094,"twenty":-9.203264,"median":-4.742734,"eighty":-3.314805,"marketCap":60909205},{"date":"2024-04-19","current":-0.969325,"twenty":-9.160911,"median":-4.686056,"eighty":-3.281552,"marketCap":51831391},{"date":"2024-04-26","current":-0.793024,"twenty":-9.045594,"median":-4.679711,"eighty":-3.256999,"marketCap":42404297},{"date":"2024-05-03","current":-0.865117,"twenty":-9.02559,"median":-4.67293,"eighty":-3.222326,"marketCap":46259233},{"date":"2024-05-10","current":-0.853881,"twenty":-9.013601,"median":-4.631996,"eighty":-3.197538,"marketCap":46259233},{"date":"2024-05-17","current":-0.842934,"twenty":-8.960201,"median":-4.600736,"eighty":-3.119794,"marketCap":45666166},{"date":"2024-05-24","current":-0.777251,"twenty":-8.87918,"median":-4.556776,"eighty":-3.079409,"marketCap":42107764},{"date":"2024-05-31","current":-0.755356,"twenty":-8.820255,"median":-4.537707,"eighty":-3.038717,"marketCap":40921629},{"date":"2024-06-07","current":-0.771777,"twenty":-8.746599,"median":-4.512325,"eighty":-2.993026,"marketCap":41811230},{"date":"2024-06-14","current":-0.925038,"twenty":-8.709772,"median":-4.502289,"eighty":-2.980329,"marketCap":50114169},{"date":"2024-06-21","current":-0.771777,"twenty":-8.664307,"median":-4.495207,"eighty":-2.939832,"marketCap":41811230},{"date":"2024-06-28","current":-0.782724,"twenty":-8.640135,"median":-4.489009,"eighty":-2.920581,"marketCap":42404297},{"date":"2024-07-05","current":-0.618516,"twenty":-8.629554,"median":-4.472533,"eighty":-2.895554,"marketCap":33508291},{"date":"2024-07-12","current":-0.717041,"twenty":-8.545779,"median":-4.46206,"eighty":-2.873326,"marketCap":38845895},{"date":"2024-07-15","current":-0.678726,"twenty":-8.525496,"median":-4.461562,"eighty":-2.868076,"marketCap":36770160},{"date":"2024-08-02","current":-0.738935,"twenty":-8.503775,"median":-4.455922,"eighty":-2.850739,"marketCap":40032029},{"date":"2024-08-09","current":-0.592364,"twenty":-8.404824,"median":-4.42544,"eighty":-2.804643,"marketCap":33211757},{"date":"2024-08-16","current":-0.571208,"twenty":-8.326387,"median":-4.418977,"eighty":-2.748595,"marketCap":32025623},{"date":"2024-08-23","current":-0.555341,"twenty":-8.193648,"median":-4.410178,"eighty":-2.718038,"marketCap":31136022},{"date":"2024-08-30","current":-0.61352,"twenty":-8.144091,"median":-4.381439,"eighty":-2.669467,"marketCap":34397891},{"date":"2024-09-06","current":-0.629387,"twenty":-8.138941,"median":-4.377791,"eighty":-2.637596,"marketCap":35287492},{"date":"2024-09-13","current":-0.756322,"twenty":-8.109177,"median":-4.364829,"eighty":-2.553047,"marketCap":42404297},{"date":"2024-09-20","current":-1.27993,"twenty":-8.065285,"median":-4.359401,"eighty":-2.472746,"marketCap":71761119},{"date":"2024-09-27","current":-1.38042,"twenty":-8.006605,"median":-4.328077,"eighty":-2.428786,"marketCap":77395256},{"date":"2024-10-04","current":-1.253485,"twenty":-7.946269,"median":-4.308243,"eighty":-2.401311,"marketCap":70278451},{"date":"2024-10-11","current":-1.17415,"twenty":-7.940236,"median":-4.278792,"eighty":-2.379331,"marketCap":65830448},{"date":"2024-10-18","current":-1.105394,"twenty":-7.928168,"median":-4.243224,"eighty":-2.324381,"marketCap":61975511},{"date":"2024-10-25","current":-1.137127,"twenty":-7.922135,"median":-4.223408,"eighty":-2.296906,"marketCap":63754713},{"date":"2024-10-31","current":-1.015481,"twenty":-7.922135,"median":-4.220076,"eighty":-2.247451,"marketCap":56934441},{"date":"2024-11-08","current":-1.02077,"twenty":-7.917308,"median":-4.210694,"eighty":-2.203491,"marketCap":57230975},{"date":"2024-11-15","current":-0.990682,"twenty":-7.877486,"median":-4.200386,"eighty":-2.163927,"marketCap":57527508},{"date":"2024-11-22","current":-1.077494,"twenty":-7.863006,"median":-4.18227,"eighty":-2.124364,"marketCap":62568579},{"date":"2024-11-29","current":-1.117565,"twenty":-7.850938,"median":-4.154565,"eighty":-1.653919,"marketCap":64895436},{"date":"2024-12-06","current":-1.144301,"twenty":-7.836458,"median":-4.134218,"eighty":-1.535604,"marketCap":66447958},{"date":"2024-12-13","current":-1.053398,"twenty":-7.828011,"median":-4.114285,"eighty":-1.501633,"marketCap":61169382},{"date":"2024-12-20","current":-0.983885,"twenty":-7.785775,"median":-4.110253,"eighty":-1.404904,"marketCap":57132824},{"date":"2024-12-27","current":-1.16569,"twenty":-7.756814,"median":-4.094935,"eighty":-1.382465,"marketCap":67689976},{"date":"2025-01-03","current":-1.181731,"twenty":-7.753194,"median":-4.069124,"eighty":-1.319715,"marketCap":68621490},{"date":"2025-01-10","current":-1.06944,"twenty":-7.753194,"median":-4.066404,"eighty":-1.306374,"marketCap":62100896},{"date":"2025-01-17","current":-1.048051,"twenty":-7.710958,"median":-4.027437,"eighty":-1.27993,"marketCap":60858878},{"date":"2025-01-24","current":-1.149648,"twenty":-7.677701,"median":-4.004689,"eighty":-1.260248,"marketCap":66758463},{"date":"2025-01-31","current":-1.037357,"twenty":-7.649549,"median":-3.985032,"eighty":-1.226534,"marketCap":60237869},{"date":"2025-02-07","current":-1.064093,"twenty":-7.561309,"median":-3.979207,"eighty":-1.20312,"marketCap":61790391},{"date":"2025-02-14","current":-0.994579,"twenty":-7.536885,"median":-3.968026,"eighty":-1.196414,"marketCap":57753833},{"date":"2025-02-21","current":-0.914371,"twenty":-7.521503,"median":-3.9572,"eighty":-1.17549,"marketCap":53096266},{"date":"2025-02-28","current":-0.892982,"twenty":-7.492892,"median":-3.932768,"eighty":-1.164843,"marketCap":51854248},{"date":"2025-03-07","current":-0.807427,"twenty":-7.444909,"median":-3.863096,"eighty":-1.158283,"marketCap":46886176},{"date":"2025-03-14","current":-0.823469,"twenty":-7.414105,"median":-3.842071,"eighty":-1.144301,"marketCap":47817689},{"date":"2025-03-21","current":-0.882288,"twenty":-7.351355,"median":-3.83198,"eighty":-1.141087,"marketCap":51233239},{"date":"2025-03-28","current":-0.976018,"twenty":-7.269298,"median":-3.811457,"eighty":-1.130407,"marketCap":59572838},{"date":"2025-04-04","current":-0.887824,"twenty":-7.236716,"median":-3.801177,"eighty":-1.115426,"marketCap":54189750},{"date":"2025-04-11","current":-0.729074,"twenty":-7.230193,"median":-3.789261,"eighty":-1.103846,"marketCap":44500192},{"date":"2025-04-17","current":-0.734953,"twenty":-7.179577,"median":-3.774363,"eighty":-1.086551,"marketCap":44859065},{"date":"2025-04-25","current":-0.858426,"twenty":-7.067737,"median":-3.746951,"eighty":-1.070619,"marketCap":52395387},{"date":"2025-05-02","current":-0.758472,"twenty":-6.968014,"median":-3.738989,"eighty":-1.063486,"marketCap":46294555},{"date":"2025-05-09","current":-0.691313,"twenty":-6.896128,"median":-3.72879,"eighty":-1.048324,"marketCap":42705829},{"date":"2025-05-16","current":-0.74855,"twenty":-6.859478,"median":-3.718608,"eighty":-1.042704,"marketCap":46241627},{"date":"2025-05-23","current":-0.844668,"twenty":-6.802547,"median":-3.708154,"eighty":-1.037357,"marketCap":52179267},{"date":"2025-05-30","current":-0.987387,"twenty":-6.754216,"median":-3.695933,"eighty":-1.028657,"marketCap":60995764},{"date":"2025-06-06","current":-1.194185,"twenty":-6.724496,"median":-3.676093,"eighty":-1.028657,"marketCap":73770689},{"date":"2025-06-13","current":-1.141758,"twenty":-6.654128,"median":-3.658244,"eighty":-1.036781,"marketCap":70531975},{"date":"2025-06-20","current":-1.613606,"twenty":-6.612475,"median":-3.654984,"eighty":-1.037357,"marketCap":99680394},{"date":"2025-06-27","current":-1.858269,"twenty":-6.583701,"median":-3.641213,"eighty":-1.037357,"marketCap":114794389},{"date":"2025-07-03","current":-2.009726,"twenty":-6.53362,"median":-3.635252,"eighty":-1.04087,"marketCap":124150671},{"date":"2025-07-11","current":-2.522352,"twenty":-6.52094,"median":-3.620168,"eighty":-1.041748,"marketCap":155818089},{"date":"2025-07-18","current":-2.504876,"twenty":-6.474846,"median":-3.596047,"eighty":-1.042513,"marketCap":154738518},{"date":"2025-07-25","current":-2.330118,"twenty":-6.463288,"median":-3.571744,"eighty":-1.042704,"marketCap":143942808},{"date":"2025-08-01","current":-2.003901,"twenty":-6.450149,"median":-3.558444,"eighty":-1.045337,"marketCap":123790814},{"date":"2025-08-08","current":-2.044678,"twenty":-6.445264,"median":-3.543057,"eighty":-1.046971,"marketCap":126309814},{"date":"2025-08-15","current":-1.777103,"twenty":-6.421957,"median":-3.518486,"eighty":-1.047884,"marketCap":110409386},{"date":"2025-08-22","current":-2.706575,"twenty":-6.404194,"median":-3.504905,"eighty":-1.048453,"marketCap":168156400},{"date":"2025-08-29","current":-3.273611,"twenty":-6.396742,"median":-3.485096,"eighty":-1.048697,"marketCap":203385711},{"date":"2025-09-05","current":-3.653269,"twenty":-6.392011,"median":-3.496086,"eighty":-1.051532,"marketCap":226973433},{"date":"2025-09-12","current":-5.493285,"twenty":-6.383596,"median":-3.504905,"eighty":-1.056035,"marketCap":341291555},{"date":"2025-09-19","current":-6.028562,"twenty":-6.373537,"median":-3.518486,"eighty":-1.05924,"marketCap":374547736},{"date":"2025-09-26","current":-8.142907,"twenty":-6.373537,"median":-3.543057,"eighty":-1.061931,"marketCap":505909592},{"date":"2025-10-03","current":-6.646648,"twenty":-6.407203,"median":-3.558444,"eighty":-1.063689,"marketCap":412948704},{"date":"2025-10-10","current":-6.351468,"twenty":-6.407203,"median":-3.571744,"eighty":-1.06666,"marketCap":394609481},{"date":"2025-10-17","current":-5.638963,"twenty":-6.397853,"median":-3.592789,"eighty":-1.069012,"marketCap":350342392},{"date":"2025-10-24","current":-5.730571,"twenty":-6.393562,"median":-3.610209,"eighty":-1.06944,"marketCap":356033875},{"date":"2025-10-31","current":-6.524505,"twenty":-6.405727,"median":-3.627238,"eighty":-1.071208,"marketCap":405360060},{"date":"2025-11-07","current":-6.738256,"twenty":-6.453431,"median":-3.639247,"eighty":-1.073827,"marketCap":418640187},{"date":"2025-11-14","current":-6.565219,"twenty":-6.504741,"median":-3.649093,"eighty":-1.076411,"marketCap":407889608},{"date":"2025-11-21","current":-7.221924,"twenty":-6.538979,"median":-3.656253,"eighty":-1.079078,"marketCap":451344069},{"date":"2025-11-28","current":-7.914154,"twenty":-6.597041,"median":-3.661921,"eighty":-1.083812,"marketCap":494605947},{"date":"2025-12-05","current":-6.91197,"twenty":-6.657384,"median":-3.682825,"eighty":-1.092068,"marketCap":431973079},{"date":"2025-12-12","current":-6.405712,"twenty":-6.657384,"median":-3.695933,"eighty":-1.098009,"marketCap":400333795},{"date":"2025-12-19","current":-5.858127,"twenty":-6.634434,"median":-3.709906,"eighty":-1.101065,"marketCap":366111712},{"date":"2025-12-26","current":-7.035952,"twenty":-6.660962,"median":-3.718608,"eighty":-1.102297,"marketCap":439721475},{"date":"2026-01-02","current":-6.798321,"twenty":-6.738256,"median":-3.726533,"eighty":-1.105394,"marketCap":424870382},{"date":"2026-01-09","current":-4.886939,"twenty":-6.757899,"median":-3.736695,"eighty":-1.106806,"marketCap":305415943},{"date":"2026-01-16","current":-4.793953,"twenty":-6.739485,"median":-3.744117,"eighty":-1.10687,"marketCap":299604646},{"date":"2026-01-23","current":-5.517178,"twenty":-6.738502,"median":-3.771529,"eighty":-1.111148,"marketCap":344803623},{"date":"2026-01-30","current":-5.031584,"twenty":-6.738256,"median":-3.780554,"eighty":-1.112218,"marketCap":314455739},{"date":"2026-02-06","current":-4.669971,"twenty":-6.736715,"median":-3.799573,"eighty":-1.116496,"marketCap":291856250},{"date":"2026-02-13","current":-5.12457,"twenty":-6.689013,"median":-3.803637,"eighty":-1.117565,"marketCap":320267036},{"date":"2026-02-20","current":-5.424192,"twenty":-6.669598,"median":-3.819277,"eighty":-1.120773,"marketCap":338992326},{"date":"2026-02-27","current":-5.155565,"twenty":-6.653805,"median":-3.83525,"eighty":-1.12612,"marketCap":322204135},{"date":"2026-03-06","current":-5.145234,"twenty":-6.628326,"median":-3.860323,"eighty":-1.130407,"marketCap":321558435},{"date":"2026-03-13","current":-6.289319,"twenty":-6.61393,"median":-3.916926,"eighty":-1.132899,"marketCap":352358446},{"date":"2026-03-20","current":-5.608457,"twenty":-6.612399,"median":-3.956689,"eighty":-1.135719,"marketCap":314213220},{"date":"2026-03-27","current":-6.023898,"twenty":-6.6085,"median":-3.966616,"eighty":-1.138307,"marketCap":337488273},{"date":"2026-04-02","current":-6.150838,"twenty":-6.597041,"median":-3.973199,"eighty":-1.14016,"marketCap":344600095},{"date":"2026-04-10","current":-6.53166,"twenty":-6.576308,"median":-3.981126,"eighty":-1.141758,"marketCap":365935561},{"date":"2026-04-17","current":-6.427799,"twenty":-6.581349,"median":-3.986625,"eighty":-1.141758,"marketCap":360116797},{"date":"2026-04-24","current":-7.078888,"twenty":-6.597041,"median":-4.01597,"eighty":-1.142021,"marketCap":396594001},{"date":"2026-05-01","current":-6.051122,"twenty":-6.609782,"median":-4.04597,"eighty":-1.142416,"marketCap":339013469},{"date":"2026-05-08","current":-6.028026,"twenty":-6.597041,"median":-4.066733,"eighty":-1.14317,"marketCap":337719524},{"date":"2026-05-15","current":-5.935642,"twenty":-6.581349,"median":-4.091001,"eighty":-1.144301,"marketCap":332543746},{"date":"2026-05-22","current":-6.203557,"twenty":-6.57278,"median":-4.110253,"eighty":-1.144301,"marketCap":337719524},{"date":"2026-05-29","current":-6.013426,"twenty":-6.564313,"median":-4.113505,"eighty":-1.14537,"marketCap":327368854},{"date":"2026-06-05","current":-5.32414,"twenty":-6.564313,"median":-4.129095,"eighty":-1.149728,"marketCap":289844360},{"date":"2026-06-12","current":-4.896307,"twenty":-6.554883,"median":-4.149422,"eighty":-1.151694,"marketCap":266553296},{"date":"2026-06-18","current":-5.24095,"twenty":-6.53166,"median":-4.177765,"eighty":-1.158283,"marketCap":285315542},{"date":"2026-06-26","current":-5.383561,"twenty":-6.524505,"median":-4.196874,"eighty":-1.158283,"marketCap":293079231},{"date":"2026-07-02","current":-6.001541,"twenty":-6.524505,"median":-4.207873,"eighty":-1.15993,"marketCap":326721880},{"date":"2026-07-10","current":-6.369953,"twenty":-6.524505,"median":-4.219024,"eighty":-1.160868,"marketCap":346778074},{"date":"2026-07-17","current":-5.680667,"twenty":-6.521781,"median":-4.221742,"eighty":-1.163058,"marketCap":309253581},{"date":"2026-07-24","current":-5.217182,"twenty":-6.52094,"median":-4.24012,"eighty":-1.165266,"marketCap":284021594},{"date":"2026-07-31","current":-5.027034,"twenty":-6.487193,"median":-4.246328,"eighty":-1.165266,"marketCap":273670010},{"date":"2026-08-07","current":-5.037876,"twenty":-6.450287,"median":-4.246328,"eighty":-1.165266,"marketCap":288550412},{"date":"2026-08-14","current":-5.873756,"twenty":-6.416237,"median":-4.246328,"eighty":-1.165266,"marketCap":336426490},{"date":"2026-08-21","current":-5.930235,"twenty":-6.401892,"median":-4.246328,"eighty":-1.165266,"marketCap":339661360},{"date":"2026-08-28","current":-5.885052,"twenty":-6.380005,"median":-4.246328,"eighty":-1.165266,"marketCap":337073464},{"date":"2026-09-04","current":-5.693025,"twenty":-6.362194,"median":-4.246328,"eighty":-1.165266,"marketCap":326074906},{"date":"2026-09-11","current":-5.162128,"twenty":-6.347909,"median":-4.246328,"eighty":-1.165266,"marketCap":295667127},{"date":"2026-09-18","current":-5.037876,"twenty":-6.28228,"median":-4.246328,"eighty":-1.165266,"marketCap":288550412},{"date":"2026-09-25","current":-4.902327,"twenty":-6.244463,"median":-4.246328,"eighty":-1.165266,"marketCap":280786724},{"date":"2026-10-02","current":-4.552161,"twenty":-6.218683,"median":-4.246328,"eighty":-1.165266,"marketCap":260730530},{"date":"2026-10-07","current":-4.326247,"twenty":-6.207216,"median":-4.246328,"eighty":-1.165266,"marketCap":247791049}],"updateTime":1791449539043},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IMRX\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2642289490","title":"Immuneering doses first patient in Phase 3 MAPKeeper 301 trial for first-line metastatic pancreatic cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2642289490","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642289490?lang=en_us&edition=fundamental","pubTime":"2026-06-11 19:33","pubTimestamp":1781177629,"startTime":"0","endTime":"0","summary":"Immuneering dosed the first patient in MAPKeeper 301, a global pivotal Phase 3 trial in first-line metastatic pancreatic cancer.The study tests atebimetinib with modified gemcitabine and nab-paclitaxel versus standard gemcitabine and nab-paclitaxel alone.Earlier survival and tolerability results were presented this year, supporting the move into a registrational trial.Topline Phase 3 results, including overall survival, are expected in mid-2028.The readout will guide whether atebimetinib can support a new first-line option in a high-need market.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Immuneering Corporation published the original content used to generate this news brief on June 11, 2026, and is solely responsible for the inform","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260611:nNDLb9JttN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK4139","BK4563","IMRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642289148","title":"Immuneering - Topline Data From Phase 3 Trial Expected in Mid-2028","url":"https://stock-news.laohu8.com/highlight/detail?id=2642289148","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642289148?lang=en_us&edition=fundamental","pubTime":"2026-06-11 19:30","pubTimestamp":1781177400,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260611:nTUA16QSGN:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","IMRX","BK4539","BK4563"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640103759","title":"Immuneering Buy Rating Reaffirmed as Analyst Sees ASCO Sell-Off as Overdone; $11 Price Target Maintained","url":"https://stock-news.laohu8.com/highlight/detail?id=2640103759","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640103759?lang=en_us&edition=fundamental","pubTime":"2026-06-02 19:37","pubTimestamp":1780400229,"startTime":"0","endTime":"0","summary":"Immuneering, the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Ami Fadia from Needham maintained a Buy rating on...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/immuneering-buy-rating-reaffirmed-as-analyst-sees-asco-sell-off-as-overdone-11-price-target-maintained-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/immuneering-buy-rating-reaffirmed-as-analyst-sees-asco-sell-off-as-overdone-11-price-target-maintained-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IMRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640960255","title":"Immuneering Advances Atebimetinib With Positive Phase 2a Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2640960255","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640960255?lang=en_us&edition=fundamental","pubTime":"2026-06-02 06:49","pubTimestamp":1780354197,"startTime":"0","endTime":"0","summary":"The latest announcement is out from Immuneering ( ($IMRX) ). On June 1, 2026, Immuneering reported updated Phase 2a data for atebimetinib, a once-d...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/immuneering-advances-atebimetinib-with-positive-phase-2a-results?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/immuneering-advances-atebimetinib-with-positive-phase-2a-results?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IMRX","BK4139","BK4539","BK4563"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640962173","title":"Immuneering - 17.3 Month Median Overall Survival Observed in 320 Mg ITT Population as of April 24, 2026 - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2640962173","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640962173?lang=en_us&edition=fundamental","pubTime":"2026-06-02 04:52","pubTimestamp":1780347175,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260601:nFWN4290J3:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IMRX","BK4539","BK4563","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640296214","title":"Immuneering - Announces Updated Phase 2a Data for Atebimetinib in Pancreatic Cancer - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2640296214","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640296214?lang=en_us&edition=fundamental","pubTime":"2026-06-02 04:52","pubTimestamp":1780347175,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260601:nFWN4290J3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4563","BK4139","BK4539","IMRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640956718","title":"Immuneering says atebimetinib plus chemo posts 17.3-month median survival in Phase 2a first-line pancreatic cancer study","url":"https://stock-news.laohu8.com/highlight/detail?id=2640956718","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640956718?lang=en_us&edition=fundamental","pubTime":"2026-06-01 19:35","pubTimestamp":1780313738,"startTime":"0","endTime":"0","summary":"Immuneering highlighted Phase 2a results already presented at the 2026 ASCO meeting for atebimetinib with chemotherapy in first-line metastatic pancreatic cancer.Patients lived longer than historical outcomes on standard chemotherapy, with responses consistent across cohorts despite different follow-up durations.The regimen showed favorable tolerability, with severe treatment-related side effects largely tied to chemotherapy rather than atebimetinib.A global Phase 3 MAPKeeper 301 trial is recruiting, with first patient dosing expected in mid-2026 to confirm the survival benefit.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Immuneering Corporation published the original content used to generate this news brief on June 01, 2026, and is","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260601:nNDLbymZrg:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4539","IMRX","BK4563"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640804959","title":"Immuneering Presents Compelling 17.3-Month Median Overall Survival and Favorable Tolerability with Atebimetinib + Chemotherapy in First-Line Pancreatic Cancer Patients at ASCO","url":"https://stock-news.laohu8.com/highlight/detail?id=2640804959","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640804959?lang=en_us&edition=fundamental","pubTime":"2026-06-01 19:30","pubTimestamp":1780313400,"startTime":"0","endTime":"0","summary":"- 17.3 months median overall survival in 55 first-line pancreatic cancer patients; vs. 8.5 months for standard of care chemotherapy in the pivotal MPACT study - - Only two categories of Grade 3+ treat","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/06/01/3304230/0/en/Immuneering-Presents-Compelling-17-3-Month-Median-Overall-Survival-and-Favorable-Tolerability-with-Atebimetinib-Chemotherapy-in-First-Line-Pancreatic-Cancer-Patients-at-ASCO.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ORR","IMRX","BK4563","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637365292","title":"Analysts Offer Insights on Healthcare Companies: Immuneering (IMRX) and Cencora (COR)","url":"https://stock-news.laohu8.com/highlight/detail?id=2637365292","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637365292?lang=en_us&edition=fundamental","pubTime":"2026-05-22 08:40","pubTimestamp":1779410407,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Immuneering (IMRX) and Cencora (COR). Immuneering (IMRX) In a rep...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-immuneering-imrx-and-cencora-cor-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-immuneering-imrx-and-cencora-cor-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0128526141.USD","LU2237957902.USD","IMRX","BK4585","BK4529","LU2324357040.USD","LU0029874061.USD","LU2237957811.SGD","LU0289739699.SGD","LU1119994496.HKD","LU1084165304.USD","HCSG","LU1261432733.SGD","LU1585245621.USD","BK4137","BK4539","BK4563","LU1814569148.SGD","LU0058720904.USD","BK4084","XBI","SG9999004303.SGD","BK4581","LABU","BK4588","LU1430594728.SGD","COR","BK4139","XLV","BK4175","SGXZ23171101.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637352099","title":"Immuneering says atebimetinib-chemo trial shows 17.3-month median survival in pancreatic cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2637352099","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637352099?lang=en_us&edition=fundamental","pubTime":"2026-05-22 05:02","pubTimestamp":1779397368,"startTime":"0","endTime":"0","summary":"Immuneering reported updated Phase 2a results for atebimetinib with chemotherapy in first-line metastatic pancreatic cancer, with full data slated for an oral presentation at the ASCO Annual Meeting on June 1, 2026.The update pointed to longer survival with manageable tolerability, with severe treatment-related side effects largely attributed to chemotherapy rather than the investigational drug.The readout supports the company’s planned randomized Phase 3 MAPKeeper 301 trial, which is recruiting with a first patient dosing targeted for mid-2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Immuneering Corporation published the original content used to generate this news brief on May 21, 2026, and is solely responsible for the informa","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260521:nNDL8m1NqH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4563","IMRX","BK4139","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637527563","title":"Immuneering Reports 17.3 Months Median Overall Survival in First-Line Metastatic Pancreatic Cancer Patients Treated With Atebimetinib Plus Chemotherapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2637527563","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637527563?lang=en_us&edition=fundamental","pubTime":"2026-05-22 05:00","pubTimestamp":1779397201,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260521:nTUA2BPV9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IMRX","BK4139","BK4563","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637369357","title":"Immuneering Corp - Only Anemia (16%) and Neutropenia (18%) Grade 3+ Adverse Events in ≥10% of Patients","url":"https://stock-news.laohu8.com/highlight/detail?id=2637369357","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637369357?lang=en_us&edition=fundamental","pubTime":"2026-05-22 05:00","pubTimestamp":1779397201,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260521:nTUA2BPV9:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BK4563","IMRX","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637357380","title":"Immuneering Corp - Full Data From 55 Patients to Be Presented at Asco on June 1, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2637357380","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637357380?lang=en_us&edition=fundamental","pubTime":"2026-05-22 05:00","pubTimestamp":1779397201,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260521:nTUA2BPV9:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BK4539","BK4563","IMRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637357336","title":"Immuneering Corp - Reports 17.3-Month Median Overall Survival as of April 24, 2026 Data Cutoff","url":"https://stock-news.laohu8.com/highlight/detail?id=2637357336","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637357336?lang=en_us&edition=fundamental","pubTime":"2026-05-22 05:00","pubTimestamp":1779397201,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260521:nTUA2BPV9:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","IMRX","BK4539","BK4563"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637338357","title":"Immuneering Corp - Phase 3 Mapkeeper 301 Trial Recruiting; First Patient Dosing Expected Mid-2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2637338357","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637338357?lang=en_us&edition=fundamental","pubTime":"2026-05-22 05:00","pubTimestamp":1779397201,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260521:nTUA2BPV9:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4563","BK4539","IMRX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637357537","title":"Immuneering Reports 17.3 Months Median Overall Survival in First-Line Metastatic Pancreatic Cancer Patients Treated with Atebimetinib Plus Chemotherapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2637357537","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637357537?lang=en_us&edition=fundamental","pubTime":"2026-05-22 05:00","pubTimestamp":1779397200,"startTime":"0","endTime":"0","summary":"- Detailed data from 55 patients to be shared in an oral presentation at the ASCO Annual Meeting on June 1, 2026 - - Tolerability profile consistent with prior updates: only two categories of Grade 3 ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/05/21/3299784/0/en/Immuneering-Reports-17-3-Months-Median-Overall-Survival-in-First-Line-Metastatic-Pancreatic-Cancer-Patients-Treated-with-Atebimetinib-Plus-Chemotherapy.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PFS","BK4539","IMRX","BK4195","BK4211","BK4563","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636862673","title":"Immuneering Is Maintained at Buy by Chardan Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2636862673","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636862673?lang=en_us&edition=fundamental","pubTime":"2026-05-20 04:45","pubTimestamp":1779223500,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/IMRX/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  May 19, 2026 16:45 ET (20:45 GMT)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IMRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636886230","title":"Immuneering (IMRX) Gets a Buy from Chardan Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2636886230","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636886230?lang=en_us&edition=fundamental","pubTime":"2026-05-20 04:35","pubTimestamp":1779222952,"startTime":"0","endTime":"0","summary":"Chardan Capital analyst Geulah Livshits reiterated a Buy rating on Immuneering today and set a price target of $20.00. Livshits covers the Healthca...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/immuneering-imrx-gets-a-buy-from-chardan-capital-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/immuneering-imrx-gets-a-buy-from-chardan-capital-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4539","BK4563","IMRX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636271480","title":"Mizuho Securities Sticks to Their Buy Rating for Immuneering (IMRX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2636271480","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636271480?lang=en_us&edition=fundamental","pubTime":"2026-05-18 18:55","pubTimestamp":1779101740,"startTime":"0","endTime":"0","summary":"In a report released today, Graig Suvannavejh from Mizuho Securities reiterated a Buy rating on Immuneering, with a price target of $12.00. Accordi...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/mizuho-securities-sticks-to-their-buy-rating-for-immuneering-imrx-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/mizuho-securities-sticks-to-their-buy-rating-for-immuneering-imrx-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IMRX","MFG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635031162","title":"Analysts Are Bullish on Top Healthcare Stocks: Immuneering (IMRX), Galectin Therapeutics (GALT)","url":"https://stock-news.laohu8.com/highlight/detail?id=2635031162","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635031162?lang=en_us&edition=fundamental","pubTime":"2026-05-16 01:30","pubTimestamp":1778866254,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Immuneering (IMRX), Galectin Therapeutics (GALT) and...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-immuneering-imrx-galectin-therapeutics-galt-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-immuneering-imrx-galectin-therapeutics-galt-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0128526141.USD","BK4588","BK4539","BK4112","BK4585","IMRX","BLSG","BK4137","XBI","BK4581","BK4563","GALT","LABU","BLSX","LU0029874061.USD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":3,"totalSize":74,"code":"91000000","status":"200"}]}}